Anaerobic culture conditions favor biofilm-like phenotypes in Pseudomonas aeruginosa isolates from patients with cystic fibrosis

FEMS Immunology and Medical Microbiology

Volumn 48, Issue 3, 2006, Pages 373-380

  O'May, Che Y ^a   Reid, David W ^a   Kirov, Sylvia M ^a  

^a UNIVERSITY OF TASMANIA   (Australia)

Author keywords

Anaerobiosis; Biofilm growth; Cystic fibrosis; Phenotype; Pseudomonas aeruginosa

Indexed keywords

ARTICLE; BACTERIUM CULTURE; BIOFILM; CONTROLLED STUDY; CYSTIC FIBROSIS; DISEASE ASSOCIATION; LABORATORY TEST; MORBIDITY; MORTALITY; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA;

ADOLESCENT; ADULT; AGED; ANAEROBIOSIS; BIOFILMS; CYSTIC FIBROSIS; HUMANS; INFANT; PHENOTYPE; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; SPUTUM;

EID: 33750964700     PISSN: 09288244     EISSN: 1574695X     Source Type: Journal    
DOI: 10.1111/j.1574-695X.2006.00157.x     Document Type: Article

References (30)

1. Alm RA & Mattick JS (1995) Identification of a gene, pilV, required for type 4 fimbrial biogenesis in Pseudomonas aeruginosa, whose product possesses a pre-pilin-like leader sequence. Mol Microbiol 16: 485-496.
2. Armstrong DS, Nixon GM, Carzino R, Bigham A, Carlin JB, Robins-Browne RM & Grimwood K (2002) Detection of a widespread clone of Pseudomonas aeruginosa in a pediatric cystic fibrosis clinic. Am J Respir Crit Care Med 166: 983-987.
3. Boucher JC, Yu H, Mudd MH & Deretic V (1997) Mucoid Pseudomonas aeruginosa in cystic fibrosis: characterization of muc mutations in clinical isolates and analysis of clearance in a mouse model of respiratory infection. Infect Immun 65: 3838-3846.
4. Costerton JW, Stewart PS & Greenberg EP (1999) Bacterial biofilms: a common cause of persistent infections. Science 284: 1318-1322.
5. Deziel E, Lepine F, Milot S & Villemur R (2003) rhIA is required for the production of a novel biosurfactant promoting swarming motility in Pseudomonas aeruginosa: 3-(3-hydroxyalkanoyloxy) alkanoic acids (HAAs), the precursors of rhamnolipids. Microbiology 149: 2005-2013.
6. Garrett ES, Perlegas D & Wozniak DJ (1999) Negative control of flagellum synthesis in Pseudomonas aeruginosa is modulated by the alternative sigma factor AlgT (AlgU). J Bacteriol 181: 7401-7404.
7. Govan JR & Deretic V (1996) Microbial pathogenesis in cystic fibrosis: mucoid Pseudomonas aeruginosa and Burkholderia cepacia. Microbiol Rev 60: 539-574.
8. Head NE & Yu H (2004) Cross-sectional analysis of clinical and environmental isolates of Pseudomonas aeruginosa: biofilm formation, virulence, and genome diversity. Infect Immun 72: 133-144.
9. Heydorn A, Nielsen AT, Hentzer M, Sternberg C, Givskov M, Ersboll BK & Molin S (2000) Quantification of biofilm structures by the novel computer program COMSTAT. Microbiology 146: 2395-2407.
10. Holloway BW (1955) Genetic recombination in Pseudomonas aeruginosa. J Gen Microbiol 13: 572-581.
11. Kirov SM, Webb JS & Kjelleberg S (2005) Clinical significance of seeding dispersal in biofilms. Microbiology 151: 3452-3453.
12. Klausen M, Heydorn A, Ragas P, Lambertsen L, Aaes-Jorgensen A, Molin S & Tolker-Nielsen T (2003) Biofilm formation by Pseudomonas aeruginosa wild type, flagella and type IV pili mutants. Mol Microbiol 48: 1511-1524.
13. Lee B, Haagensen JA, Ciofu O, Andersen JB, Hoiby N & Molin S (2005) Heterogeneity of biofilms formed by nonmucoid Pseudomonas aeruginosa isolates from patients with cystic fibrosis. J Clin Microbiol 43: 5247-5255.
14. Luzar MA, Thomassen MJ & Montie TC (1985) Flagella and motility alterations in Pseudomonas aeruginosa strains from patients with cystic fibrosis: relationship to patient clinical condition. Infect Immun 50: 577-582.
15. Lyczak JB, Cannon CL & Pier GB (2002) Lung infections associated with cystic fibrosis. Clin Microbiol Rev 15: 194-222.
16. Mahenthiralingam E, Campbell ME & Speert DP (1994) Nonmotility and phagocytic resistance of Pseudomonas aeruginosa isolates from chronically colonized patients with cystic fibrosis. Infect Immun 62: 596-605.
17. Mahenthiralingam E, Campbell ME, Foster J, Lam JS & Speert DP (1996) Random amplified polymorphic DNA typing of Pseudomonas aeruginosa isolates recovered from patients with cystic fibrosis. J Clin Microbiol 34: 1129-1135.
18. Meyer JM & Abdallah MA (1978) The fluorescent pigment of Pseudomonas fluorescens: biosynthesis, purification and physiochemical properties. J Gen Microbiol 107: 319-328.
19. O'Toole GA & Kolter R (1998) Flagellar and twitching motility are necessary for Pseudomonas aeruginosa biofilm development. Mol Microbiol 30: 295-304.
20. O'Toole GA, Pratt LA, Watnick PI, Newman DK, Weaver VB & Kolter R (1999) Genetic approaches to study of biofilms. Methods Enzymol 310: 91-109.
21. Sauer K, Camper AK, Ehrlich GD, Costerton JW & Davies DG (2002) Pseudomonas aeruginosa displays multiple phenotypes during development as a biofilm. J Bacteriol 184: 1140-1154.
22. Singh PK, Schaefer AL, Parsek MR, Moninger TO, Welsh MJ & Greenberg EP (2000) Quorum-sensing signals indicate that cystic fibrosis lungs are infected with bacterial biofilms. Nature 407: 762-764.
23. Sriramulu DD, Lunsdorf H, Lam JS & Romling U (2005) Microcolony formation: a novel biofilm model of Pseudomonas aeruginosa for the cystic fibrosis lung. J Med Microbiol 54: 667-676.
24. Stoodley P, Sauer K, Davies DG & Costerton JW (2002) Biofilms as complex differentiated communities. Annu Rev Microbiol 56: 187-209.
25. Tart AH, Wolfgang MC & Wozniak DJ (2005) The alternative sigma factor AlgT represses Pseudomonas aeruginosa flagellum biosynthesis by inhibiting expression of fleQ. J Bacteriol 187: 7955-7962.
26. Tatterson LE, Poschet JF, Firoved A, Skidmore J & Deretic V (2001) CFTR and Pseudomonas infections in cystic fibrosis. Front Biosci 6: 890-897.
27. Watson AA, Mattick JS & Alm RA (1996) Functional expression of heterologous type 4 fimbriae in Pseudomonas aeruginosa. Gene 175: 143-150.
28. Worlitzsch D, Tarran R, Ulrich M et al. (2002) Effects of reduced mucus oxygen concentration in airway Pseudomonas infections of cystic fibrosis patients. J Clin Invest 109: 317-325.
29. Wu M, Guina T, Brittnacher M, Nguyen H, Eng J & Miller SI (2005) The Pseudomonas aeruginosa proteome during anaerobic growth. J Bacteriol 187: 8185-8190.
30. Yoon SS, Hennigan RF, Hilliard GM et al. (2002) Pseudomonas aeruginosa anaerobic respiration in biofilms: relationships to cystic fibrosis pathogenesis. Dev Cell 3: 593-603.